SARS-CoV-2 诱导的免疫失调以及 COVID-19 患者需要更高的临床警惕以识别合并感染和继发感染。
SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.
机构信息
American University of Caribbean, School of Medicine, Sint Maarten.
School of Tropical Medicine and Global Health, Nagasaki University, Japan; Institute of Research and Development, Duy Tan University, Da Nang 550000, Viet Nam.
出版信息
J Microbiol Immunol Infect. 2021 Feb;54(1):105-108. doi: 10.1016/j.jmii.2020.08.016. Epub 2020 Sep 8.
Abstract
Cases of co-infection and secondary infection emerging during the current Coronavirus Disease-19 (COVID-19) pandemic are a major public health concern. Such cases may result from immunodysregulation induced by the SARS-CoV-2 virus. Pandemic preparedness must include identification of disease natural history and common secondary infections to implement clinical solutions.
摘要
当前的新型冠状病毒病（COVID-19）大流行期间出现的合并感染和继发感染病例是一个主要的公共卫生关注点。此类病例可能是由 SARS-CoV-2 病毒引起的免疫失调所致。大流行防范必须包括确定疾病自然史和常见的继发感染，以实施临床解决方案。
相似文献
1
SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.
J Microbiol Immunol Infect. 2021 Feb;54(1):105-108. doi: 10.1016/j.jmii.2020.08.016. Epub 2020 Sep 8.
2
SARS-CoV-2 superinfection in CD14 monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade.
Virus Res. 2024 Jul;345:199375. doi: 10.1016/j.virusres.2024.199375. Epub 2024 Apr 22.
3
A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center.
Med Sci Monit. 2020 Nov 14;26:e928754. doi: 10.12659/MSM.928754.
4
Concerns and public health challenges for arboviral and other respiratory infections amidst SARS-CoV-2 pandemic.
Pathog Glob Health. 2020 Dec;114(8):405-406. doi: 10.1080/20477724.2020.1826154. Epub 2020 Sep 25.
5
Viral infections amidst COVID-19 in Africa: Implications and recommendations.
J Med Virol. 2021 Dec;93(12):6798-6802. doi: 10.1002/jmv.27211. Epub 2021 Jul 22.
6
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia.
Rev Med Virol. 2021 Mar;31(2):e2161. doi: 10.1002/rmv.2161. Epub 2020 Sep 18.
7
Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.
J Med Virol. 2021 Apr;93(4):2385-2395. doi: 10.1002/jmv.26740. Epub 2020 Dec 29.
8
Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms.
Scand J Immunol. 2021 Feb;93(2):e12967. doi: 10.1111/sji.12967. Epub 2020 Sep 14.
9
Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C Virus.
Clin Infect Dis. 2020 Nov 19;71(16):2233-2235. doi: 10.1093/cid/ciaa408.
10
COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia.
Eur J Haematol. 2020 Oct;105(4):508-511. doi: 10.1111/ejh.13475. Epub 2020 Jul 10.
引用本文的文献
1
Pulmonary microbial spectrum in late-stage SARS-CoV-2 infection: a case series.
Eur J Clin Microbiol Infect Dis. 2024 Oct;43(10):2037-2046. doi: 10.1007/s10096-024-04897-6. Epub 2024 Jul 20.
2
SARS-CoV-2 Related Viral Respiratory Co-Infections: A Narrative Review.
Tanaffos. 2023 Jan;22(1):19-26.
3
Progress of cGAS-STING signaling in response to SARS-CoV-2 infection.
Front Immunol. 2022 Dec 7;13:1010911. doi: 10.3389/fimmu.2022.1010911. eCollection 2022.
4
Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients.
J Clin Med. 2022 Nov 29;11(23):7080. doi: 10.3390/jcm11237080.
5
COVID-19 Associated with Cryptococcosis: A New Challenge during the Pandemic.
J Fungi (Basel). 2022 Oct 21;8(10):1111. doi: 10.3390/jof8101111.
6
The Menace of Epidemic Amidst the COVID-19 Pandemic: A Systematic Review.
Diseases. 2022 Aug 29;10(3):58. doi: 10.3390/diseases10030058.
7
Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19.
J Mycol Med. 2022 May;32(2):101251. doi: 10.1016/j.mycmed.2022.101251. Epub 2022 Jan 31.
8
Disseminated Coccidioidomycosis Following COVID-19 Mimicking Metastatic Thoracic Relapse of Well-Differentiated Liposarcoma: A Case Report.
Front Med (Lausanne). 2021 Sep 13;8:715939. doi: 10.3389/fmed.2021.715939. eCollection 2021.
9
Eosinophilic appendicitis due to : a challenging differential diagnosis for clinicians.
BMJ Case Rep. 2021 Jun 1;14(6):e239685. doi: 10.1136/bcr-2020-239685.
10
8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load.
Sci Rep. 2021 May 3;11(1):9440. doi: 10.1038/s41598-021-88714-6.
本文引用的文献
1
Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.
Anesth Analg. 2020 Oct;131(4):993-999. doi: 10.1213/ANE.0000000000005044.
2
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
J Microbiol Immunol Infect. 2020 Aug;53(4):505-512. doi: 10.1016/j.jmii.2020.05.013. Epub 2020 May 23.
3
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).
Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.
4
Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study.
Microbes Infect. 2020 May-Jun;22(4-5):195-199. doi: 10.1016/j.micinf.2020.05.007. Epub 2020 May 18.
5
The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
JCI Insight. 2020 May 21;5(10):137799. doi: 10.1172/jci.insight.137799.
6
CoViD-19 Immunopathology and Immunotherapy.
Bioinformation. 2020 Mar 31;16(3):219-222. doi: 10.6026/97320630016219. eCollection 2020.
7
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.
J Infect Dis. 2020 May 11;221(11):1762-1769. doi: 10.1093/infdis/jiaa150.
8
Clinical and immunological features of severe and moderate coronavirus disease 2019.
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
9
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
Zotero 插件